KayoThera

KayoThera is a biotechnology company focused on developing innovative therapeutics aimed at treating late-stage and metastatic cancers. Founded in 2019 and based in Princeton, New Jersey, the company specializes in creating first-in-class immuno- and targeted therapies. Its primary approach involves inhibiting a key enzyme that protects cancer cells and depleting regulatory T-cells, which enhances the effectiveness of existing chemotherapy and immunotherapy treatments. KayoThera's mission is to provide new hope for patients facing previously incurable cancers by advancing its therapeutic programs.